These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 23443726

  • 1. Age-related changes in 11β-hydroxysteroid dehydrogenase type 2 activity in normotensive subjects.
    Campino C, Martinez-Aguayo A, Baudrand R, Carvajal CA, Aglony M, Garcia H, Padilla O, Kalergis AM, Fardella CE.
    Am J Hypertens; 2013 Apr; 26(4):481-7. PubMed ID: 23443726
    [Abstract] [Full Text] [Related]

  • 2. Urinary free cortisol is not a biochemical marker of hypertension.
    Krall P, Carvajal C, Ortiz E, Muñoz C, Garrido JL, Mosso L, Fardella C.
    Am J Hypertens; 2007 Apr; 20(4):459-65. PubMed ID: 17386356
    [Abstract] [Full Text] [Related]

  • 3. [11 beta-hydroxysteroid dehydrogenase type 2 activity in Chilean patients with hypertension].
    Mosso L, Carvajal C, Campino C, Rojas A, González A, Barraza A, Montero J, Fardella C.
    Rev Med Chil; 2002 Nov; 130(11):1201-8. PubMed ID: 12587501
    [Abstract] [Full Text] [Related]

  • 4. Assessing systemic 11beta-hydroxysteroid dehydrogenase with serum cortisone/cortisol ratios in healthy subjects and patients with diabetes mellitus and chronic renal failure.
    Homma M, Tanaka A, Hino K, Takamura H, Hirano T, Oka K, Kanazawa M, Miwa T, Notoya Y, Niitsuma T, Hayashi T.
    Metabolism; 2001 Jul; 50(7):801-4. PubMed ID: 11436185
    [Abstract] [Full Text] [Related]

  • 5. Age-dependent decrease in 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) activity in hypertensive patients.
    Henschkowski J, Stuck AE, Frey BM, Gillmann G, Dick B, Frey FJ, Mohaupt MG.
    Am J Hypertens; 2008 Jun; 21(6):644-9. PubMed ID: 18443572
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. 11beta-Hydroxysteroid dehydrogenase type 2 activity is associated with left ventricular mass in essential hypertension.
    Glorioso N, Filigheddu F, Parpaglia PP, Soro A, Troffa C, Argiolas G, Mulatero P.
    Eur Heart J; 2005 Mar; 26(5):498-504. PubMed ID: 15618035
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Placental 11beta-hydroxysteroid dehydrogenase type 2 is reduced in pregnancies complicated with idiopathic intrauterine growth Restriction: evidence that this is associated with an attenuated ratio of cortisone to cortisol in the umbilical artery.
    Dy J, Guan H, Sampath-Kumar R, Richardson BS, Yang K.
    Placenta; 2008 Feb; 29(2):193-200. PubMed ID: 18061258
    [Abstract] [Full Text] [Related]

  • 10. Altered activity of 11beta-hydroxysteroid dehydrogenase types 1 and 2 in skeletal muscle confers metabolic protection in subjects with type 2 diabetes.
    Jang C, Obeyesekere VR, Dilley RJ, Krozowski Z, Inder WJ, Alford FP.
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3314-20. PubMed ID: 17519316
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Use of 11alpha-deuterium labeled cortisol as a tracer for assessing reduced 11beta-HSD2 activity in vivo following glycyrrhetinic acid ingestion in a human subject.
    Kasuya Y, Yokokawa A, Takashima S, Shibasaki H, Furuta T.
    Steroids; 2005 Feb; 70(2):117-25. PubMed ID: 15631868
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Alteration of the activity of the 11beta-hydroxysteroid dehydrogenase in pregnancy: relevance for the development of pregnancy-induced hypertension?
    Heilmann P, Buchheim E, Wacker J, Ziegler R.
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5222-6. PubMed ID: 11701681
    [Abstract] [Full Text] [Related]

  • 15. Impaired protein stability of 11beta-hydroxysteroid dehydrogenase type 2: a novel mechanism of apparent mineralocorticoid excess.
    Atanasov AG, Ignatova ID, Nashev LG, Dick B, Ferrari P, Frey FJ, Odermatt A.
    J Am Soc Nephrol; 2007 Apr; 18(4):1262-70. PubMed ID: 17314322
    [Abstract] [Full Text] [Related]

  • 16. Regulation of 11beta-hydroxysteroid dehydrogenase type 2 by diuretics and the renin-angiotensin-aldosterone axis.
    Ricketts ML, Stewart PM.
    Clin Sci (Lond); 1999 Jun; 96(6):669-75. PubMed ID: 10334975
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Placental 11beta-HSD2 activity, early postnatal clinical course, and adrenal function in extremely low birth weight infants.
    Kajantie E, Dunkel L, Turpeinen U, Stenman UH, Andersson S.
    Pediatr Res; 2006 Apr; 59(4 Pt 1):575-8. PubMed ID: 16549532
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Expression of renal 11beta-hydroxysteroid dehydrogenase type 2 is decreased in patients with impaired renal function.
    Quinkler M, Zehnder D, Lepenies J, Petrelli MD, Moore JS, Hughes SV, Cockwell P, Hewison M, Stewart PM.
    Eur J Endocrinol; 2005 Aug; 153(2):291-9. PubMed ID: 16061836
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.